DIAX: Merger On The Table, The Discount To NAV Could Shrink
Source: SeekingAlpha
2025-10-02 08:25:28 ET
Thesis
We have covered the Nuveen Dow 30 Dynamic Overwrite Fund ( DIAX ) several times in the past on the Seeking Alpha platform. The name is a buy-write CEF from Nuveen that has poor structuring and poor long-term results. Our issue with DIAX has always been around its Dow Jones to S&P 500 basis, a structural item that we highlighted in our last article on the website....
Read the full article on Seeking Alpha
For further details see:
DIAX: Merger On The Table, The Discount To NAV Could Shrink
Nuveen S&P 500 Buy-Write Income Fund of Beneficial Interest
NASDAQ: BXMX
BXMX Trading
-1.66% G/L:
$14.20 Last:
30,306 Volume:
$14.31 Open:
BXMX Latest News
March 05, 2026 04:15:00 pm
Nuveen Covered Call Closed-End Funds Announce Shareholder Approval of Proposed Mergers
September 19, 2025 04:15:00 pm
Nuveen Covered Call Closed-End Funds Announce Proposed Mergers and Shareholder Meeting Update
